simendan has been researched along with Ventricular Fibrillation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SA; Chien, YS; Hsieh, YC; Huang, JL; Li, CH; Lin, JC; Lin, SF; Lin, YJ; Weng, CJ; Wu, SJ | 1 |
| Bleser, T; Görge, G; Weth, C | 1 |
| Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Kohnke, A; Pott, C | 1 |
| Carbucicchio, C; Grazi, M; Lauri, G; Marenzi, G | 1 |
| Cammarata, G; Cao, L; Huang, L; Sun, S; Tang, W; Weil, MH | 1 |
| Bassiakou, E; Goulas, S; Koudouna, E; Lelovas, P; Papadimitriou, D; Papadimitriou, L; Tsirikos, N; Xanthos, T | 1 |
6 other study(ies) available for simendan and Ventricular Fibrillation
| Article | Year |
|---|---|
Levosimendan attenuates electrical alternans and prevents ventricular arrhythmia during therapeutic hypothermia in isolated rabbit hearts.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Heart; Hypothermia, Induced; Rabbits; Simendan; Ventricular Fibrillation | 2023 |
[Reverse takotsubo cardiomyopathy-a life-threatening disease. Successful resuscitation of a 31-year-old woman with cardiologic shock after a visit to the dentist].
Topics: Adult; Anesthesia, Dental; Anesthesia, Local; Apicoectomy; Combined Modality Therapy; Dental Anxiety; Electrocardiography; Female; Fluid Therapy; Heart Ventricles; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Phosphopyruvate Hydratase; Pyridazines; Radiography; Resuscitation; Shock, Cardiogenic; Simendan; Takotsubo Cardiomyopathy; Ventricular Fibrillation | 2013 |
Experimental evidence for a severe proarrhythmic potential of levosimendan.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Heart Conduction System; Hydrazones; Infusions, Intravenous; Pyridazines; Rabbits; Severity of Illness Index; Simendan; Treatment Outcome; Ventricular Fibrillation | 2017 |
Use of levosimendan for treatment of cardiogenic shock associated with electrical storm.
Topics: Cardiotonic Agents; Defibrillators, Implantable; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan; Tachycardia, Ventricular; Ventricular Fibrillation | 2009 |
Levosimendan improves postresuscitation outcomes in a rat model of CPR.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Output; Cardiopulmonary Resuscitation; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Heart Arrest; Heart Rate; Hydrazones; Male; Pyridazines; Random Allocation; Rats; Rats, Sprague-Dawley; Simendan; Single-Blind Method; Survival Rate; Ventricular Fibrillation; Ventricular Function, Left | 2005 |
Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest.
Topics: Adrenergic alpha-Agonists; Animals; Cardiopulmonary Resuscitation; Cardiotonic Agents; Disease Models, Animal; Drug Therapy, Combination; Epinephrine; Female; Heart Arrest; Hydrazones; Male; Pyridazines; Random Allocation; Simendan; Swine; Treatment Outcome; Ventricular Fibrillation | 2007 |